Short answer
Oncology Institute, Inc. (TOI) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Item 2.02 concerns fiscal-year 2026 results, with substantive figures contained in Exhibit 99.1.
Oncology Institute, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 concerns fiscal-year 2026 results, with substantive figures contained in Exhibit 99.1
- Furnished under Regulation FD rather than filed under Exchange Act Section 18
- Section 18 liability protections limit the filing’s use in certain Exchange Act contexts
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oncology Institute, Inc. 8-K filings
Get the next TOI 8-K as it lands
Follow TOI for push alerts, or ask the research agent what this filing means.